Letter to the EditorIntravenously Injected Recombinant Human Type VII Collagen Homes to Skin Wounds and Restores Skin Integrity of Dystrophic Epidermolysis Bullosa
Under an Elsevier user license
open archive
Cited by (0)
Dr Mei Chen and Dr David Woodley are consultants for Lotus Tissue Repair, Inc. and hold stock in the company. Dr Mei Chen, Dr David T. Woodley, and the University of Southern California hold patents for recombinant type VII collagen and have filed a Conflict of Interest Declaration with Dr Randoph W. Hall, Vice Provost for Research Advancement at the University of Southern California.
Copyright © 2013 The Society for Investigative Dermatology, Inc. All rights reserved.